Medical specialty societies were founded on two key principles: knowledge sharing and the exchange of clinical insights to improve medical practice. That central task has evolved as societies use clinical data registries to serve diverse and important stakeholders who are also involved in ensuring optimal health outcomes.
These clinical data registry stakeholders include:
Societies and their registries are vehicles to further data-driven care through collaboration with these health care stakeholders. New opportunities frequently arise for registries to add unique value through the data insights they provide — especially through partnerships with life science organizations.
Specifically, there are four common ways for registries to empower life science organizations with new understandings in patient outcomes. These opportunities further support real-time insights in clinical care.
Let’s examine each to understand their value to industry and value to your mission.
Patient cohort analytics are useful in several ways. They provide analytic tools to facilitate activities like clinical trial enrollment and registry cohort comparison for research.
Registries transform raw data into tools that provide tremendous value to trial sponsors in two ways:
Simply stated, registries provide real-time answers to common post-market surveillance questions, like:
Clinical decision support tools convert retrospective registry data into powerful point-of-care tools with immediate impact on patient care.
Decision support tools are built to take the guess work out of trade-off decisions between treatment courses. With real-world data and a user-friendly interface, decision support apps are valuable resources. They enable clinicians and patients to prioritize outcomes and establish appropriate expectations.
At the same time, decision support tools can be designed to demonstrate the degree to which device or pharmaceutical factors drive outcomes. These tools create significant value for industry stakeholders and set the stage for value-based reimbursement.
Registry-based clinical trials (RBCTs) set the gold standard for creating value for multiple stakeholders.
RBCTs rely on the registry’s network of participating clinicians, their patients, and the foundational registry dataset. They identify participating investigators and clinicians, facilitate patient enrollment, and support the majority of data elements required for trial completion. Registries also capture specialized clinical trial data through custom patient surveys, electronic case report forms, and data mapping.
The process ultimately leads to a clinical trial completion that is much quicker and more cost-effective than traditional methods.
There are a few key steps to determining your organization’s readiness for registry data partnerships with industry.
Registries are powerful tools for effectively generating new clinical insights for key stakeholders and creating meaningful partnerships with life science companies.
These stakeholder collaborations use registries to employ valuable data tools to evaluate and improve patient outcomes, and in the process, help to further support the operations of registries and their underlying missions.
ArborMetrix offers an industry-leading, proven registry solution that meets the needs of medical device and pharma companies, medical specialty societies, and clinicians.
If you have any questions or would like to learn more about how our registry solutions can support deeper engagements with health care stakeholders, contact me at email@example.com.
Check out the following articles for more like this.